News

Keep you updated

with the latest info of XtalPi

XtalPi and Baicheng Medicine Announce Strategic Collaboration to Advance Innovative Drug Development
XtalPi Leadership Visits China Merchants Group to Explore Strategic Collaboration in AI-Driven Innovation
XtalPi Announces Milestone Achievement in Collaboration with PharmaEngine on Next-Generation PRMT5 Inhibitor PEP08
Signet Therapeutics, Incubated by XtalPi, Nominated for 2025 Prix Galien USA Best Biotechnology Award for First-in-Class Diffuse Gastric Cancer Drug SIGX1094R
XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies
XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration
XtalPi Innovation Center and JingJiaHang BioPharma Announce Strategic Collaboration to Advance AI-Driven Radionuclide Drug Development
XtalPi Invests in MIT-Led Foundry Bio, Harnessing Generative AI to Transform the Trillion-Dollar Anti-Aging Market
XtalPi’s “New Paradigm in Synthetic Chemistry: AI and Robotics Symposium” Concludes Successfully
XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations 
XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC), Unlocking Unprecedented Power in Chemical Space Exploration
XtalPi Opens AI Drug Discovery Platform to Faculty and Students at China Pharmaceutical University

Search XtalPi

Unlock Faster, Smarter Polymorph Screening with XtalGazer™ CSP
Unlock Faster, More Accurate Drug Discovery with XFEP
Templated Nucleation of Clotrimazole and Ketoprofen on Polymer Substrates

XtalPi Newsletter